Spectrum of anti tubercular therapy induced cutaneous adverse drug reactions and its management through rechallenge: a prospective study at a Tertiary Care Centre
B Modi, J Modha - Indian Journal of Tuberculosis, 2022 - Elsevier
Introduction The use of multi-drug regimens including 1st and 2nd line anti tubercular drugs
in management of tuberculosis (TB) has been associated with undesirable adverse drug …
in management of tuberculosis (TB) has been associated with undesirable adverse drug …
[HTML][HTML] Spectrum of cutaneous adverse drug reactions to anti-tubercular drugs and safe therapy after re-challenge-A retrospective study
RK Sharma, GK Verma, GR Tegta, S Sood… - Indian Dermatology …, 2020 - journals.lww.com
Background: Tuberculosis (TB) is a major global health problem and leading cause of death.
Anti-tubercular therapy (ATT) can lead to various adverse effects including cutaneous …
Anti-tubercular therapy (ATT) can lead to various adverse effects including cutaneous …
Cutaneous drug reaction secondary to antitubercular regimen: A case report from Nepal
HB Bhattarai, J Yadav, S Sapkota… - … Open Medical Case …, 2023 - journals.sagepub.com
Cutaneous adverse drug reactions are known side effects of first-line antitubercular therapy,
which ranges from mild pruritus to life-threatening toxic epidermal necrolysis. Severe …
which ranges from mild pruritus to life-threatening toxic epidermal necrolysis. Severe …
Adverse drug reactions in tuberculosis and management
R Prasad, A Singh, N Gupta - Indian Journal of Tuberculosis, 2019 - Elsevier
Background Treatment of drug susceptible tuberculosis (DS-TB) requires regimens
containing first line drugs (FLDs') whereas drug resistant tuberculosis (DR-TB) are treated …
containing first line drugs (FLDs') whereas drug resistant tuberculosis (DR-TB) are treated …
Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions
RJ Lehloenya, G Todd, M Badri… - The International journal …, 2011 - ingentaconnect.com
BACKGROUND: Data regarding outcomes of tuberculosis (TB) associated cutaneous
adverse drug reactions (CADR) are limited. The re-introduction of first-line anti-tuberculosis …
adverse drug reactions (CADR) are limited. The re-introduction of first-line anti-tuberculosis …
Drug-Induced Hypersensitivity Reaction and Re-Introduction of Anti-Tubercular Drugs (ATT): A Case Report and Review of Literature
G Gupta, AK Das, J Kirtana, U Baitha… - Journal of Drug Delivery …, 2023 - jddtonline.info
Tuberculosis (TB) is a communicable disease caused by the bacillus Mycobacterium
tuberculosis and is the leading cause of death by a single infectious agent overall …
tuberculosis and is the leading cause of death by a single infectious agent overall …
[PDF][PDF] Two years review of cutaneous adverse drug reaction from first line anti-tuberculous drugs
WC Tan, CK Ong, SCL Kang, MA Razak - Medical Journal of Malaysia, 2007 - e-mjm.org
First line Anti-TB therapy with rifampicin, isoniazid, pyrazinamide, and ethambutol/
streptomycin is very effective. However, major adverse reactions to antituberculous drugs …
streptomycin is very effective. However, major adverse reactions to antituberculous drugs …
Pharmacovigilance of Antitubercular Therapy in Tuberculosis
R Mirunalini, R Manju, M Malathi - Cureus, 2022 - search.proquest.com
Background Adverse drug reactions (ADRs) to tuberculosis (TB) drugs are a significant
concern for medical professionals and health authorities. Adverse events due to drug …
concern for medical professionals and health authorities. Adverse events due to drug …
[HTML][HTML] Pharmacovigilance of antitubercular therapy in tuberculosis
M Ravichandran, M Rajaram, M Munusamy - Cureus, 2022 - ncbi.nlm.nih.gov
Background Adverse drug reactions (ADRs) to tuberculosis (TB) drugs are a significant
concern for medical professionals and health authorities. Adverse events due to drug …
concern for medical professionals and health authorities. Adverse events due to drug …
Pulmonary tuberculosis with fixed drug eruption to all first-line anti-tuberculosis drugs
G Amanda, F Nurwidya, F Isbaniyah - 2017 - jag.journalagent.com
Tuberculosis (TB) is still one of the leading causes of mortality worldwide. Treatment with
anti-TB drugs sometimes results in side effects for patients, including drug reactions, both …
anti-TB drugs sometimes results in side effects for patients, including drug reactions, both …